Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Galldiks N et al. – The present data suggest that in patients with recurrent GBM the metabolically active tumour volume may be substantially underestimated by Gd–DTPA enhancement. The findings support the notion that complementary information derived from MET uptake and Gd–DTPA enhancement may be helpful in developing individualized, patient–tailored therapy strategies in patients with recurrent GBM.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address